100 related articles for article (PubMed ID: 1956554)
1. Protective role of BCG in the rabbit model of mesangial proliferative glomerulonephritis.
Xu JJ; Qian TS; Xin CY; Wu YJ; Huang ZC
Nephrol Dial Transplant; 1991; 6(8):554-6. PubMed ID: 1956554
[TBL] [Abstract][Full Text] [Related]
2. Experimental proliferative glomerulonephritis in the cat.
Bishop SA; Stokes CR; Lucke VM
J Comp Pathol; 1992 Jan; 106(1):49-60. PubMed ID: 1556257
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
4. The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis.
Mauer SM; Sutherland DE; Howard RJ; Fish AJ; Najarian JS; Michael AF
J Exp Med; 1973 Mar; 137(3):553-70. PubMed ID: 4570015
[TBL] [Abstract][Full Text] [Related]
5. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
6. Studies in molecular pathology. I. Localization and pathogenic role of heterologous immune complexes.
MELLORS RC; BRZOSKO WJ
J Exp Med; 1962 May; 115(5):891-902. PubMed ID: 14472423
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
8. Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.
Groggel GC; Adler S; Rennke HG; Couser WG; Salant DJ
J Clin Invest; 1983 Dec; 72(6):1948-57. PubMed ID: 6227634
[TBL] [Abstract][Full Text] [Related]
9. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
10. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
Strife CF; McAdams AJ; West CD
Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
[TBL] [Abstract][Full Text] [Related]
11. Tissue deposition of immune complexes in mice receiving daily injections of bovine serum albumin.
Noble B; Olson KA; Milgrom M; Albini B
Clin Exp Immunol; 1980 Nov; 42(2):255-62. PubMed ID: 6451337
[TBL] [Abstract][Full Text] [Related]
12. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Tsuboi Y; Shankland SJ; Grande JP; Walker HJ; Johnson RJ; Dousa TP
J Clin Invest; 1996 Jul; 98(2):262-70. PubMed ID: 8755633
[TBL] [Abstract][Full Text] [Related]
13. Immunoelectron microscopy of cationized bovine serum albumin-induced glomerulonephritis in the rabbit.
al-Nawab MD; Bass PS; Das AK; Davies DR
J Pathol; 1992 May; 167(1):33-40. PubMed ID: 1625056
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis.
Holdsworth SR; Neale TJ
Lab Invest; 1984 Aug; 51(2):172-80. PubMed ID: 6611452
[TBL] [Abstract][Full Text] [Related]
15. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T; Oka M; Maesato K; Mano T; Ikee R; Moriya H; Kobayashi S
Hypertens Res; 2008 Mar; 31(3):387-94. PubMed ID: 18497456
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
Nakazawa M; Emancipator SN; Lamm ME
J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
[TBL] [Abstract][Full Text] [Related]
17. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Nephron; 1998; 79(2):206-14. PubMed ID: 9647502
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenic factor (Dampness-heat) of glomerulopathy].
Yu JY; Xiong NN
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Aug; 12(8):458-60, 451. PubMed ID: 1477499
[TBL] [Abstract][Full Text] [Related]
19. Glomerulonephritis and chronic myelogenous leukemia.
Springate JE; Brecher M; Brentjens J; Feld LG
Child Nephrol Urol; 1988-1989; 9(5):298-300. PubMed ID: 2978736
[TBL] [Abstract][Full Text] [Related]
20. Electron microscopic studies of experimental nephritis with ferritin-conjugated antibody. Localization of antigen-antibody complexes in rabbit glomeruli following repeated injections of bovine serum albumin.
ANDRES GA; SEEGAL BC; HSU KC; ROTHENBERG MS; CHAPEAU ML
J Exp Med; 1963 Apr; 117(4):691-704. PubMed ID: 14013043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
